UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv238-iv255

2018

Volltextzugriff (PDF)

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Annals of oncology, 2021-06, Vol.32 (6), p.801-805

2021

Volltextzugriff (PDF)

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma

Oncogene, 2014-07, Vol.33 (28), p.3748-3752

2014

Volltextzugriff (PDF)

Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 29 suppl. 4 (2018) v238–iv255]

Annals of oncology, 2022-06, Vol.33 (6), p.666-666

2022

Volltextzugriff (PDF)

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-05, Vol.30 (5), p.871-873

2019

Volltextzugriff (PDF)

Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

Annals of oncology, 2019-05, Vol.30 (5), p.871-873

2019

Volltextzugriff (PDF)

Molecular perspectives for the treatment of hepatocellular carcinoma

Acta gastro-enterologica belgica, 2020-04, Vol.83 (2), p.309-312

2020

Volltextzugriff (PDF)

Long-term survival after hospital discharge in cirrhotic patients previously hospitalized in intensive care unit for an acute event: a 6 year cohort study

Journal of hepatology, 2017, Vol.66 (1), p.S122-S122

2017

Volltextzugriff (PDF)

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S446-S446

2017

Volltextzugriff (PDF)

Genotype-Phenotype Correlation of CTNNB1 Mutations Reveals Different B-Catenin Activation Levels in Hepatocellular Tumors with High Activity Associated with Malignancy

Journal of hepatology, 2016, Vol.64 (2), p.S578-S578

2016

Volltextzugriff (PDF)

P0359 : ESM-1 is a marker of microvascular invasion, satellite nodules, and adverse clinical outcome in patients with hepatocellular carcinoma treated by surgical resection

Journal of hepatology, 2015-04, Vol.62, p.S445-S445

2015

Volltextzugriff (PDF)

O075 : Assessment of the transjugular porto-systemic shunt (TIPSS) in the management of complications of noncirrhotic portal hypertension

Journal of hepatology, 2015-04, Vol.62, p.S228-S228

2015

Volltextzugriff (PDF)

G05 : Exome sequencing of 243 liver tumors identifies new mutational signatures and potential therapeutic targets

Journal of hepatology, 2015-04, Vol.62, p.S189-S189

2015

Volltextzugriff (PDF)

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

Journal of hepatocellular carcinoma, 2022, Vol.9, p.1369-1383

2022

Volltextzugriff (PDF)

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

The lancet oncology, 2022-01, Vol.23 (1), p.161-171

2022

Volltextzugriff (PDF)

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

Annals of oncology, 2019-08, Vol.8 (8), p.1615818-1615818

2019

Volltextzugriff (PDF)

Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

Clinical cancer research, 2012-12, Vol.18 (24), p.6714-6722

2012

Volltextzugriff (PDF)

76 A MOLECULAR SIGNATURE AND ALGORITHM FOR THE DIAGNOSIS AND PROGNOSIS OF HEPATOCELLULAR TUMORS

Journal of hepatology, 2011-03, Vol.54, p.S34-S34

2011

Volltextzugriff (PDF)

20PDynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

Annals of oncology, 2018-12, Vol.29 (suppl_10)

2018

Volltextzugriff (PDF)

64 EXPRESSION OF BILIARY CELL CYTOKERATIN BY HEPATOCYTES IN NON TUMORAL LIVER BIOPSY IS RELATED TO SUBSEQUENT HEPATOCELLULAR CARCINOMA OCCURRENCE IN HCV RELATED CIRRHOSIS

Journal of hepatology, 2009, Vol.50, p.S27-S28

2009

Volltextzugriff (PDF)

THU-011 - Long-term survival after hospital discharge in cirrhotic patients previously hospitalized in intensive care unit for an acute event: a 6 year cohort study

Journal of hepatology, 2017, Vol.66 (1), p.S122-S122

2017

Volltextzugriff (PDF)

SAT-132 - AAV2 viral infection in liver and tumor development

Journal of hepatology, 2018-04, Vol.68, p.S664-S665

2018

Volltextzugriff (PDF)

AAV2 viral infection in liver and tumor development

Journal of hepatology, 2018-04, Vol.68, p.S664-S665

2018

Volltextzugriff (PDF)

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up††FootnotesApproved by the ESMO Guidelines Committee: August 2018

Annals of oncology, 2018-10, Vol.29, p.iv238-iv255

2018

Volltextzugriff (PDF)

FRI-074 - Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S446-S446

2017

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma

Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 29 suppl. 4 (2018) v238–iv255]

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

Molecular perspectives for the treatment of hepatocellular carcinoma

Long-term survival after hospital discharge in cirrhotic patients previously hospitalized in intensive care unit for an acute event: a 6 year cohort study

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Genotype-Phenotype Correlation of CTNNB1 Mutations Reveals Different B-Catenin Activation Levels in Hepatocellular Tumors with High Activity Associated with Malignancy

P0359 : ESM-1 is a marker of microvascular invasion, satellite nodules, and adverse clinical outcome in patients with hepatocellular carcinoma treated by surgical resection

O075 : Assessment of the transjugular porto-systemic shunt (TIPSS) in the management of complications of noncirrhotic portal hypertension

G05 : Exome sequencing of 243 liver tumors identifies new mutational signatures and potential therapeutic targets

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

76 A MOLECULAR SIGNATURE AND ALGORITHM FOR THE DIAGNOSIS AND PROGNOSIS OF HEPATOCELLULAR TUMORS

20PDynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

64 EXPRESSION OF BILIARY CELL CYTOKERATIN BY HEPATOCYTES IN NON TUMORAL LIVER BIOPSY IS RELATED TO SUBSEQUENT HEPATOCELLULAR CARCINOMA OCCURRENCE IN HCV RELATED CIRRHOSIS

THU-011 - Long-term survival after hospital discharge in cirrhotic patients previously hospitalized in intensive care unit for an acute event: a 6 year cohort study

SAT-132 - AAV2 viral infection in liver and tumor development

AAV2 viral infection in liver and tumor development

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up††FootnotesApproved by the ESMO Guidelines Committee: August 2018

FRI-074 - Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Suchergebnisse filtern